Rallybio to Provide Update on RLYB116 Program, an Innovative Subcutaneously Injected C5 ...
Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into ...
Merck says injectable Keytruda succeeded in late-stage trial
Merck (NYSE:MRK) announced Tuesday that a subcutaneously delivered version of its blockbuster cancer therapy pembrolizumab ...